15.01.2026
New Success Story: nanoPD
The nanoPD project focuses on modeling biological barriers in vitro using multi-compartment microfluidic chips containing human midbrain organoids to develop new theranostics for Parkinson's Disease (PD).
These organoids, derived from PD patient-specific induced pluripotent stem cells (iPSCs), exhibit neurodegeneration phenotypes, allowing for personalized disease modeling.
Read more about the success stories of projects funded within the M-ERA.NET Calls: here